Bank of America Securities analyst Steve Byrne downgrades DuPont de Nemours Inc (NYSE: DD) stock from Buy to Underperform, raising the price target from $78 to $80. Citing concerns over DuPont's modest earnings recovery in 2024, undervalued PFAS liabilities, and the $1.2 billion AFFF MDL settlement, Byrne highlights potential risks from PFAS news flow and personal injury litigation, despite increased EPS estimates due to improvements in U.S. housing starts.
Financial GuidanceWe are providing our initial 2024 second quarter financial guidance and affirming our full year 2024 guidance today, which includes our current forecasted business mix assumptions, including as related
Together with reporting its annual financial results and pipeline update, short-acting psychedelics developer Small Pharma Inc. (OTCQB: DMTTF) stated its intentions to
This past week, several stories have been published about false allegations from a baseless lawsuit against DoorDash.
Let’s set the record straight: DoorDash does not charge more based on the type of phone you